tetrandrine has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, Y; Ji, B | 1 |
| Chen, J; Chen, S; Fan, Y; He, D; Li, L; Liu, W; Ma, J; Wang, K; Wang, X; Zeng, J | 1 |
2 other study(ies) available for tetrandrine and Kidney Neoplasms
| Article | Year |
|---|---|
Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Benzylisoquinolines; Carcinoma, Renal Cell; Caspases; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Humans; Kidney Neoplasms; Signal Transduction; Time Factors | 2014 |
Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Kidney Neoplasms; Matrix Metalloproteinase 9; NF-kappa B; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |